Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenues:
Chronic illness monitoring supplies revenues	$ 1,037,179	$ 1,858,926	$ 4,311,955	$ 4,972,196
Chronic illness monitoring fee revenues	159,025	317,156	599,339	888,453
Total Chronic illness monitoring revenues	1,196,204	2,176,082	4,911,294	5,860,649
Cost of revenues:
Chronic illness monitoring supplies cost of revenues	733,143	1,269,828	3,054,086	3,878,972
Chronic illness monitoring fee cost of revenues	114,954	112,486	319,184	358,436
Total Chronic illness monitoring cost of revenues	848,097	1,382,314	3,373,270	4,237,408
Gross profit	348,107	793,768	1,538,024	1,623,241
Operating expenses:
Selling, general and administrative (including $1,461,457, $1,004,211, $2,101,037 and $3,257,614, respectively, of stock-based compensation)	3,225,054	2,169,603	6,382,027	6,944,098
Research and development	56,191	57,611	307,137	139,023
Total operating expenses	3,281,245	2,227,214	6,689,164	7,083,121
Loss from operations	(2,933,138)	(1,433,446)	(5,151,140)	(5,459,880)
Other income (expense):
Interest expense, net	(2,198,631)	(813,517)	(6,856,258)	(1,935,486)
Loss on settlement	(750,000)		(750,000)
Gain on derivatives liability	64,145	5,603,411	230,163	2,796,542
Loss on extinguishment of debt		(15,393)	(2,499,212)	(3,058,809)
Gain on disposal of property and equipment				245
Gain on liability settlements		8,859		295,099
Loss on induced conversions of debt				(379,132)
Other income	2,614		2,614
Total other income (expense)	(2,881,872)	4,783,360	(9,872,693)	(2,281,541)
Net income (loss)	(5,815,010)	3,349,914	(15,023,833)	(7,741,421)
Deemed dividends on redemption of preferred stock				(6,484,236)
Dividends on preferred stock	(58,978)	(45,781)	(127,335)	(699,250)
Net loss attributable to common stockholders	$ (5,873,988)	$ 3,304,133	$ (15,151,168)	$ (14,924,907)
Net loss per common share - basic	$ (24.77)	$ 15.18	$ (64.81)	$ (81.57)
Net loss per common share - diluted	$ (24.77)	$ (3.78)	$ (64.81)	$ (82.78)
Weighted average common shares outstanding - basic	237,100	217,595	233,767	182,979
Weighted average common shares outstanding - diluted	237,100	260,266	233,767	201,928

ACTIVECARE, INC. 10-Q